Eloxx (ELOX) 10% holder swaps Pre-Funded Warrants into common stock
Rhea-AI Filing Summary
Eloxx Pharmaceuticals, Inc. reported that 10% owner Domicilium Real Estate Fund III LP, through affiliated investment entities, restructured its position in pre-funded warrants and common stock. Several transactions coded "J" as "other acquisition or disposition" reflect exchanges of Pre-Funded Warrants into common shares pursuant to their terms.
Footnotes state that each Pre-Funded Warrant was exchanged for one share of Eloxx common stock and that the warrants have no expiration date and are exercisable at any time, subject to a 19.99% beneficial ownership cap. All holdings are reported as indirect, through funds and LLCs advised by Domicilium and managed by Daniel Simon. No open-market purchases or sales are reported in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Pre-funded Warrant | 238,422 | $0.00 | $0.00 |
| Other | Pre-funded Warrant | 361,578 | $0.00 | $0.00 |
| Other | common stock, $0.01 par value per share | 238,422 | $0.00 | $0.00 |
| Other | common stock, $0.01 par value per share | 361,578 | $0.00 | $0.00 |
| holding | Pre-funded Warrant | -- | -- | -- |
| holding | Pre-funded Warrant | -- | -- | -- |
| holding | common stock, $0.01 par value per share | -- | -- | -- |
Footnotes (7)
- F1. Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.
- F2. The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium"), the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner.
- F3. The securities are owned directly by BKJLAGG, LLC ("BKJLAGG") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to BKJLAGG, and (ii) Daniel Simon, the managing member of Domicilium.
- F4. The securities may be deemed to be indirectly beneficially owned by (i) Domicilium, and (ii) Daniel Simon, the managing member of Domicilium.
- F5. The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
- F6. The securities are owned directly by MSEK Charleston LLC ("MSEK") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to MSEK, and (ii) Daniel Simon, the managing member of Domicilium.
- F7. The securities are owned directly by Bold Stroke Investments, LLC ("Bold Stroke") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to Bold Stroke, and (ii) Daniel Simon, the managing member of Domicilium.
Key Figures
Key Terms
Pre-Funded Warrants financial
beneficially owned financial
ten percent owner financial
exercise price financial
indirect ownership financial
AI-generated analysis. How Rhea-AI works. Not financial advice.